Giles Platford Discusses Strengthening the Plasma Ecosystem for Patients Worldwide at PPF2025
Giles Platford, President, Plasma-Derived Therapies Business Unit at Takeda and Chair of the Global Executive Board at PPTA, shared on LinkedIn:
”At this year’s Plasma Protein Forum, it was rewarding to join colleagues and partners from across the industry in conversations focused on strengthening sustainability of the plasma ecosystem, and advancing access to PDTs.
We heard from many compelling speakers, and I appreciated the contributions of my Takeda colleagues in sharing their expertise to advance knowledge across the value chain.
Thomas R. Kreil offered important perspectives on innovations in plasma testing and manufacturing, while Thomas Szatkowski demonstrated tangible examples of how we are applying AI and machine learning to transform the way we collect, process and deliver plasma therapies.
The meeting also placed considerable emphasis on navigating the regulatory uncertainties we face both in the US and globally, centering, as always, the needs of patients and donors.
Thank you to the Plasma Protein Therapeutics Association (PPTA) for convening such an engaging and forward-looking forum.
These moments of shared learning and collaboration are essential as we work together to ensure more patients can benefit from the life-saving potential of plasma.”
More from PPF2025 featured in Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis